S&P 500   4,594.62
DOW   34,899.34
QQQ   391.20
S&P 500   4,594.62
DOW   34,899.34
QQQ   391.20
S&P 500   4,594.62
DOW   34,899.34
QQQ   391.20
S&P 500   4,594.62
DOW   34,899.34
QQQ   391.20
NASDAQ:GHSI

Guardion Health Sciences Stock Forecast, Price & News

$1.13
+0.03 (+2.73%)
(As of 11/26/2021 12:00 AM ET)
Add
Compare
Today's Range
$1.05
$1.14
50-Day Range
$1.01
$1.55
52-Week Range
$0.96
$8.40
Volume
180,179 shs
Average Volume
2.20 million shs
Market Capitalization
$27.60 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
0.17
30 days | 90 days | 365 days | Advanced Chart
Receive GHSI News and Ratings via Email

Sign-up to receive the latest news and ratings for Guardion Health Sciences and its competitors with MarketBeat's FREE daily newsletter.


About Guardion Health Sciences

Guardion Health Sciences, Inc.is a clinical nutrition and diagnostics company, which develops medical foods and medical devices in the ocular health space and develops nutraceutical products to provide supportive health benefits to consumers. The firm operates through the following segments Medical Foods and Nutraceuticals & Medical Devices. The Medical Devices segment includes a portfolio of medical diagnostic devices currently focused on the ocular space and contrast testing. The Medical Foods and Nutraceuticals segment provides a portfolio of science-based, clinically supported nutrition, medical foods, and supplements. Its products include Lumega-Z, GlaucoCetin, ImmuneSF, VectorVision, and MapcatSF. The company was founded by Michael Favish in 2009 and is headquartered in San Diego, CA.

Headlines

Pre-market Movers: CXDC, CRTX, ANGN, GHSI, BIMI…
October 27, 2021 |  markets.businessinsider.com
See More Headlines

Industry, Sector and Symbol

Industry
Pharmaceutical preparations
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:GHSI
Employees
13
Year Founded
N/A

Sales & Book Value

Annual Sales
$1.89 million
Book Value
$1.50 per share

Profitability

Net Income
$-8.57 million
Net Margins
-282.96%
Pretax Margin
-282.98%

Debt

Price-To-Earnings

Miscellaneous

Free Float
23,572,000
Market Cap
$27.60 million
Optionable
Not Optionable

Company Calendar

Last Earnings
8/12/2019
Today
11/28/2021
Fiscal Year End
12/31/2021
Next Earnings (Estimated)
3/25/2022

MarketRank

Overall MarketRank

1.36 out of 5 stars

Medical Sector

1126th out of 1,391 stocks

Pharmaceutical Preparations Industry

539th out of 669 stocks

Analyst Opinion: 0.0Community Rank: 4.5Dividend Strength: 0.0Insider Behavior: 1.7Valuation: 0.6 5 -4 -3 -2 -1 -












Guardion Health Sciences (NASDAQ:GHSI) Frequently Asked Questions

How has Guardion Health Sciences' stock price been impacted by COVID-19 (Coronavirus)?

Guardion Health Sciences' stock was trading at $2.34 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, GHSI shares have decreased by 51.7% and is now trading at $1.13.
View which stocks have been most impacted by COVID-19
.

Are investors shorting Guardion Health Sciences?

Guardion Health Sciences saw a decrease in short interest during the month of November. As of November 15th, there was short interest totaling 671,200 shares, a decrease of 84.6% from the October 31st total of 4,360,000 shares. Based on an average daily volume of 2,080,000 shares, the short-interest ratio is presently 0.3 days. Currently, 2.8% of the company's shares are short sold.
View Guardion Health Sciences' Short Interest
.

When is Guardion Health Sciences' next earnings date?

Guardion Health Sciences is scheduled to release its next quarterly earnings announcement on Friday, March 25th 2022.
View our earnings forecast for Guardion Health Sciences
.

How were Guardion Health Sciences' earnings last quarter?

Guardion Health Sciences, Inc. (NASDAQ:GHSI) issued its quarterly earnings results on Monday, August, 12th. The company reported ($0.84) earnings per share (EPS) for the quarter. The firm earned $0.26 million during the quarter. Guardion Health Sciences had a negative net margin of 282.96% and a negative trailing twelve-month return on equity of 35.94%.
View Guardion Health Sciences' earnings history
.

When did Guardion Health Sciences' stock split? How did Guardion Health Sciences' stock split work?

Shares of Guardion Health Sciences reverse split on the morning of Monday, March 1st 2021. The 1-6 reverse split was announced on Friday, February 26th 2021. The number of shares owned by shareholders was adjusted after the closing bell on Friday, February 26th 2021. An investor that had 100 shares of Guardion Health Sciences stock prior to the reverse split would have 17 shares after the split.

Who are Guardion Health Sciences' key executives?

Guardion Health Sciences' management team includes the following people:
  • Bret D. Scholtes, President, Chief Executive Officer & Director (LinkedIn Profile)
  • David W. Evans, Director & Chief Science Officer
  • Craig J. Sheehan, Chief Commercial Officer
  • Jeffrey S. Benjamin, Chief Accounting Officer
  • Vincent J. Roth, Secretary

What other stocks do shareholders of Guardion Health Sciences own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Guardion Health Sciences investors own include iBio (IBIO), Biocept (BIOC), Onconova Therapeutics (ONTX), Heat Biologics (HTBX), VBI Vaccines (VBIV), Inovio Pharmaceuticals (INO), Ocugen (OCGN), Tonix Pharmaceuticals (TNXP), Co-Diagnostics (CODX) and FuelCell Energy (FCEL).

When did Guardion Health Sciences IPO?

(GHSI) raised $6 million in an IPO on Friday, April 5th 2019. The company issued 1,500,000 shares at $4.00 per share. WallachBeth Capital and Westpark Capital served as the underwriters for the IPO.

What is Guardion Health Sciences' stock symbol?

Guardion Health Sciences trades on the NASDAQ under the ticker symbol "GHSI."

Who are Guardion Health Sciences' major shareholders?

Guardion Health Sciences' stock is owned by many different institutional and retail investors. Top institutional investors include Renaissance Technologies LLC (2.39%), BlackRock Inc. (2.30%), Morgan Stanley (1.14%), Millennium Management LLC (0.34%) and Two Sigma Advisers LP (0.10%).
View institutional ownership trends for Guardion Health Sciences
.

Which institutional investors are selling Guardion Health Sciences stock?

GHSI stock was sold by a variety of institutional investors in the last quarter, including Morgan Stanley, and BlackRock Inc..
View insider buying and selling activity for Guardion Health Sciences
or view top insider-selling stocks.

Which institutional investors are buying Guardion Health Sciences stock?

GHSI stock was acquired by a variety of institutional investors in the last quarter, including Renaissance Technologies LLC, Millennium Management LLC, and Two Sigma Advisers LP.
View insider buying and selling activity for Guardion Health Sciences
or or view top insider-buying stocks.

How do I buy shares of Guardion Health Sciences?

Shares of GHSI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Guardion Health Sciences' stock price today?

One share of GHSI stock can currently be purchased for approximately $1.13.

How much money does Guardion Health Sciences make?

Guardion Health Sciences has a market capitalization of $27.60 million and generates $1.89 million in revenue each year. The company earns $-8.57 million in net income (profit) each year or ($0.67) on an earnings per share basis.

How many employees does Guardion Health Sciences have?

Guardion Health Sciences employs 13 workers across the globe.

What is Guardion Health Sciences' official website?

The official website for Guardion Health Sciences is www.guardionhealth.com.

Where are Guardion Health Sciences' headquarters?

Guardion Health Sciences is headquartered at 15150 AVENUE OF SCIENCE SUITE 200, SAN DIEGO CA, 92128.

How can I contact Guardion Health Sciences?

Guardion Health Sciences' mailing address is 15150 AVENUE OF SCIENCE SUITE 200, SAN DIEGO CA, 92128. The company can be reached via phone at (800) 873-5141, via email at [email protected], or via fax at 858-630-5543.


This page was last updated on 11/28/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.